In more strokeworthy medical terminology...

Quote:

Antimicrobial resistance in N. gonorrhoeae remains an important challenge to controlling gonorrhea; gonococcal strains may be resistant to penicillins, tetracyclines, spectinomycin, and fluoroquinolones. Resistance to CDC-recommended doses of ciprofloxacin and ofloxacin exceeds 40% in some Asian countries (World Health Organization (WHO) Western Pacific Region Gonococcal Antimicrobial Susceptibility Programme (GASP) Report- 2000. Commun Dis Intell 2001; 25:274-277).


Fluoroquinolone-resistant strains of N. gonorrhoeae have also been reported in the United States and Canada. The proportion of gonococcal isolates in Hawaii that are fluoroquinolone-resistant currently exceeds 13% and increasing numbers of resistant strains have been identified in the continental United States (Gonococcal Isolate Surveillance Project (GISP) Annual Report - 2003).


Antimicrobial resistance in N. gonorrhoeae occurs as plasmid-mediated resistance to penicillin and tetracycline, and chromosomally mediated resistance to penicillins, tetracyclines, spectinomycin, and fluoroquinolones.



Somehow it sounds better that way. In related dissappointing news, the CDC had this to say about bacterial vaginoisis (BV)...

Quote:

BV is not completely understood by scientists, and the best ways to prevent it are unknown. However, it is known that BV is associated with having a new sex partner or having multiple sex partners. It is seldom found in women who have never had intercourse.



Not a great week to be whore.